Abbott Laboratories
ABT
$106.89
-$0.70-0.65%
| Weiss Ratings | ABT - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Good | |||
| Risk Index | Fair | |||
| Risk Grade | C | |||
| Reward Grade | B | |||
| Rating Factors | ABT - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | Fair | |||
| Growth Index | Good | |||
| Efficiency Index | Excellent | |||
| Solvency Index | Excellent | |||
| Total Return Index | Weak | |||
| Volatility Index | Fair | |||
| Beta / Standard Deviation | ABT - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 0.71 | |||
| Price History | ABT - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -1.87% | |||
| 30-Day Total Return | -10.97% | |||
| 60-Day Total Return | -4.43% | |||
| 90-Day Total Return | 0.37% | |||
| Year to Date Total Return | -2.56% | |||
| 1-Year Total Return | -3.08% | |||
| 2-Year Total Return | -11.21% | |||
| 3-Year Total Return | -13.90% | |||
| 5-Year Total Return | 44.30% | |||
| 52-Week High % Change | -11.98% | |||
| 52-Week Low % Change | 19.40% | |||
| Price | ABT - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $121.64 | |||
| 52-Week Low Price | $89.67 | |||
| 52-Week Low Price (Date) | Oct 12, 2023 | |||
| 52-Week High Price (Date) | Mar 08, 2024 | |||
| Valuation | ABT - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 186.15B | |||
| Enterprise Value | 194.97B | |||
| Price/Earnings (TTM) | 32.92 | |||
| Earnings Per Share (TTM) | 3.26 | |||
| Earnings Per Share Growth | -16.57% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 4.68 | |||
| Price/Book (Q) | 4.82 | |||
| Enterprise Value/Revenue (TTM) | 4.85 | |||
| Price | $107.07 | |||
| Enterprise Value/EBITDA (TTM) | 18.69 | |||
| Enterprise Value/EBIT | 27.15 | |||
| Market Cap Category | Large Cap | |||
| Dividends and Shares | ABT - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 1.75B | |||
| Dividend Yield | 1.98% | |||
| Div. Per Share (Most Recent) | $0.55 | |||
| Dividend Per Share (TTM) | $2.12 | |||
| Payout Ratio (TTM) | 62.14% | |||
| Dividend Per Share (Most Recent) | $0.55 | |||
| Company Info | ABT - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 224 667 6100 | |||
| Address | 100 Abbott Park Road North Chicago, IL 60064-6400 | |||
| Website | www.abbott.com | |||
| Country | United States | |||
| Year Founded | 1888 | |||
| Profitability | ABT - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | 17.86% | |||
| Profit Margin | 14.26% | |||
| Management Effectiveness | ABT - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | 6.07% | |||
| Return on Equity | 15.11% | |||
| Income Statement | ABT - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 40.11B | |||
| Total Revenue (TTM) | 40.11B | |||
| Revenue Per Share | $22.95 | |||
| Gross Profit (TTM) | 22.18B | |||
| EBITDA (TTM) | 10.41B | |||
| EBIT (TTM) | 7.17B | |||
| Net Income (TTM) | 5.72B | |||
| Net Income Avl. to Common (TTM) | 5.72B | |||
| Total Revenue Growth (Q YOY) | 1.49% | |||
| Earnings Growth (Q YOY) | 54.31% | |||
| EPS Diluted (TTM) | 3.26 | |||
| EPS Diluted Growth (Q YOY) | 55.01% | |||
| Balance Sheet | ABT - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 7.28B | |||
| Cash Per Share (Q) | $4.16 | |||
| Total Current Assets (Q) | 22.67B | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 38.83B | |||
| Current Ratio (Q) | 1.638 | |||
| Book Value Per Share (Q) | $22.26 | |||
| Total Assets (Q) | 73.21B | |||
| Total Current Liabilities (Q) | 13.84B | |||
| Total Debt (Q) | 15.87B | |||
| Total Liabilities (Q) | 34.39B | |||
| Total Common Equity (Q) | 38.60B | |||
| Cash Flow | ABT - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -3.13B | |||
| Cash from Financing (TTM) | -7.09B | |||
| Net Change in Cash (TTM) | -2.99B | |||
| Levered Free Cash Flow (TTM) | 4.94B | |||
| Cash from Operations (TTM) | 7.26B | |||
